Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2018, Scanderia Venture is a venture capital organization based in Białystok, Poland. The firm focuses on supporting innovative projects primarily in the life sciences, medtech, healthcare, ICT, and biomedical engineering sectors. Scanderia Venture aims to provide both financial and substantive support to startups, helping them navigate the complexities of bringing innovative products to market.
As of now, Scanderia Venture manages a portfolio of nine companies and has a maximum investment limit of €250,000 per project. The organization is also involved in initiatives co-financed by the European Union, specifically aimed at incubating R&D projects in the life sciences and ICT sectors. This involvement underscores their commitment to fostering innovation and commercialization on a global scale.
Scanderia Venture operates from two offices located in Białystok and Warsaw, allowing them to support startups across Poland and foreign entities operating within the country. Their focus on early-stage investments aligns with their mission to back projects that demonstrate innovative potential and can achieve global commercialization.
Scanderia Venture invests in startups at the pre-seed and seed stages, particularly those that exhibit innovation and potential for global commercialization. The firm has a maximum investment limit of €250,000 and focuses on several key sectors, including medtech, biomedical engineering, biological products, and information and communication technologies (ICT) for healthcare.
Investment criteria include a strong emphasis on protectable intellectual property (IP) and a competent founding team. Scanderia Venture seeks projects that can demonstrate a defensible advantage in global markets. Their investment strategy is particularly relevant for technical founders, researchers, and clinicians working on R&D-heavy projects in life sciences and healthcare.
Scanderia Venture's engagement extends beyond capital; they provide substantive support to help startups refine their business models and navigate the complexities of product development. This dual approach of financial backing and operational assistance positions them as a valuable partner for early-stage companies.
Scanderia Venture's portfolio includes nine notable projects, showcasing their commitment to supporting innovative startups. The following companies are part of their investment portfolio:
These companies reflect Scanderia Venture's focus on sectors such as healthcare, biotech, and medtech, aligning with their investment thesis of supporting projects with global commercialization potential.
Łukasz Kośnik - Listed as a team member on Scanderia Venture's LinkedIn profile. Specific role details are not disclosed, but he is part of the organization supporting innovative projects.
Agnieszka Dobrzyńska - Another team member listed on the firm's LinkedIn profile. Her role is not specified, but she contributes to the firm's mission of supporting early-stage startups.
Jędrzej Kozioł - Listed as part of the Scanderia Venture team. His specific responsibilities are not detailed, but he plays a role in the firm's investment activities.
Paulina Ślisz-Sandecka - Also listed on the firm's LinkedIn profile. Her role is not disclosed, but she is involved in supporting the firm's portfolio companies.
To pitch Scanderia Venture, founders should use the contact form available on their website or email projekty@scanderiaventure.com. It is advisable to include a detailed overview of the project, highlighting its innovative aspects and potential for commercialization.
While there is no specific application cycle disclosed, founders should be prepared for a potentially lengthy decision timeline. Scanderia Venture encourages pitches from innovative startups, particularly those in their focus sectors.
Warm introductions are not explicitly required, but they can enhance the chances of a successful pitch. Founders should ensure their projects align closely with Scanderia's investment criteria to improve their chances of securing funding.
As of the latest updates, Scanderia Venture has not announced any new investments or exits following the conclusion of the BRIdge Alfa project in 2023. The firm remains active in its support of innovative projects but has not disclosed any recent funding activities.
Given the high-staleness risk associated with Scanderia Venture, founders are encouraged to verify the current investment capacity of the firm before proceeding with pitches. The lack of recent public announcements may indicate a pause in new investment activities.
What are Scanderia Venture's investment criteria?
Scanderia Venture looks for early-stage projects that demonstrate innovation, protectable intellectual property, and a competent founding team. They focus on sectors such as healthcare, biotech, and ICT.
How can I pitch to Scanderia Venture?
Founders can pitch their projects by reaching out via the contact form on their website or by emailing projekty@scanderiaventure.com. They encourage submissions from innovative startups in their focus sectors.
What is the typical check size for investments?
Scanderia Venture typically invests up to €250,000 in each project, focusing on pre-seed and seed stage startups.
What geographic areas does Scanderia Venture focus on?
The firm primarily invests in Polish startups but is also open to foreign entities operating in Poland, particularly those aligned with their investment thesis.
What kind of support does Scanderia Venture provide to portfolio companies?
In addition to capital, Scanderia Venture offers substantive support to help startups refine their business models and navigate the complexities of product development and market entry.
How competitive are Scanderia Venture's deals?
Given their focus on early-stage, innovative projects, competition for funding can be significant. Founders should ensure their projects align closely with Scanderia's investment criteria to enhance their chances of securing funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.